Kurtuluş Aksu
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Health top 5%
- Vaccine Coverage and Hesitancy
Papers in
- Physiology 20
- Asthma and respiratory diseases 19
-
- Respiratory and Cough-Related Research 10
- Inhalation and Respiratory Drug Delivery 6
- Chronic Obstructive Pulmonary Disease (COPD) Research 6
- Co-authors
- Emel Kurt (11 shared papers)Hale Ateş (14 shared papers)Özkan Alataş (3 shared papers)Pınar Özkan (2 shared papers)Zafer Gülbaş (3 shared papers)Kadir Okhan Akın (1 shared paper)Nermin Çapan (1 shared paper)Bünyamin Yavuz (1 shared paper)
In The Last Decade
Kurtuluş Aksu
47 papers receiving 1.1k citations
Kurtuluş Aksu's Hit Papers
Peers
Comparison fields: 5 of 87
- Infectious Diseases 599
- Health 164
- Modeling and Simulation 49
- Immunology and Allergy 43
- Physiology 146
Countries citing papers authored by Kurtuluş Aksu
This map shows the geographic impact of Kurtuluş Aksu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurtuluş Aksu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurtuluş Aksu more than expected).
Fields of papers citing papers by Kurtuluş Aksu
This network shows the impact of papers produced by Kurtuluş Aksu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurtuluş Aksu. The network helps show where Kurtuluş Aksu may publish in the future.
Co-authors
The 25 scholars most cited alongside Kurtuluş Aksu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey Hit paper breakdown → | 2021 | 701 |
| 2 | 2013 | 45 | |
| 3 | 2009 | 30 | |
| 4 | 2011 | 29 | |
| 5 | 2021 | 28 | |
| 6 | 2022 | 22 | |
| 7 | 2014 | 19 | |
| 8 | 2021 | 19 | |
| 9 | 2020 | 16 | |
| 10 | 2012 | 16 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 12 | |
| 13 | 2011 | 12 | |
| 14 | 2023 | 11 | |
| 15 | 2022 | 11 | |
| 16 | 2021 | 10 | |
| 17 | 2016 | 10 | |
| 18 | 2021 | 9 | |
| 19 | 2011 | 9 | |
| 20 | 2020 | 8 |
About Kurtuluş Aksu
Kurtuluş Aksu is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Pharmacology, Rheumatology and Infectious Diseases, having authored 62 papers that have together received 1.1k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (19 papers), Drug-Induced Adverse Reactions (11 papers), Respiratory and Cough-Related Research (10 papers), Inhalation and Respiratory Drug Delivery (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Urticaria and Related Conditions (5 papers), COVID-19 Clinical Research Studies (4 papers) and Allergic Rhinitis and Sensitization (4 papers). The work is most often cited by research in Infectious Diseases (599 citations), Health (164 citations), Modeling and Simulation (49 citations), Immunology and Allergy (43 citations) and Physiology (146 citations). Kurtuluş Aksu has collaborated with scholars based in Türkiye, Cambodia and Kuwait. Frequent co-authors include Emel Kurt, Hale Ateş, Özkan Alataş, Pınar Özkan, Zafer Gülbaş, Kadir Okhan Akın, Nermin Çapan, Bünyamin Yavuz, Tuğrul Şipit and Sebahat Aksaray. Their work appears in journals such as Allergy and Asthma Proceedings, World Allergy Organization Journal, Journal of Asthma and Allergy, Dermatologic Therapy and BMC Pulmonary Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.